Fidelity Advisor Biotechnology Fund - Class M (FBTTX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
34.10
+0.09 (0.26%)
May 19, 2026, 4:00 PM EST
FBTTX Holdings Information
FBTTX is a mutual fund with a total of 96 individual holdings. The top holdings are AbbVie stock at 15.52%, Alnylam Pharmaceuticals at 6.00%, Gilead Sciences at 5.87%, Insmed at 4.28%, and Cogent Biosciences at 3.77%.
Total Holdings
96
Top 10 Percentage
50.43%
Asset Class
Equity
Fund Category
Health
Assets
1.90B
Forward PE Ratio
18.53
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ABBV | AbbVie Inc. | 15.52% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.00% |
| 3 | GILD | Gilead Sciences, Inc. | 5.87% |
| 4 | INSM | Insmed Incorporated | 4.28% |
| 5 | COGT | Cogent Biosciences, Inc. | 3.77% |
| 6 | ASND | Ascendis Pharma A/S | 3.29% |
| 7 | DNTH | Dianthus Therapeutics, Inc. | 3.27% |
| 8 | ARGX | argenx SE | 3.01% |
| 9 | BIIB | Biogen Inc. | 2.88% |
| 10 | AMGN | Amgen Inc. | 2.54% |
| 11 | PCVX | Vaxcyte, Inc. | 2.37% |
| 12 | SYRE | Spyre Therapeutics, Inc. | 2.28% |
| 13 | NUVL | Nuvalent, Inc. | 2.26% |
| 14 | APGE | Apogee Therapeutics, Inc. | 2.04% |
| 15 | VRDN | Viridian Therapeutics, Inc. | 1.86% |
| 16 | ORKA | Oruka Therapeutics, Inc. | 1.86% |
| 17 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.81% |
| 18 | MRNA | Moderna, Inc. | 1.74% |
| 19 | XENE | Xenon Pharmaceuticals Inc. | 1.42% |
| 20 | n/a | Fidelity Cash Central Fund | 1.37% |
| 21 | RVMD | Revolution Medicines, Inc. | 1.26% |
| 22 | ROIV | Roivant Sciences Ltd. | 1.25% |
| 23 | GPCR | Structure Therapeutics Inc. | 1.24% |
| 24 | EBR: UCB | UCB SA | 1.22% |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 1.17% |
As of Mar 31, 2026